Impact of stopping therapy during the SARS-CoV-2 pandemic in persons with lymphoma

INTRODUCTION: The severe acute respiratory syndrome-2 (SARS-CoV-2) pandemic disrupted medical care for persons with cancer including those with lymphoma. Many professional societies recommend postponing, decreasing, or stopping anti-cancer therapy in selected persons during the pandemic. Although se...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shenmiao, Dong, Dong, Gu, Hongfei, Gale, Robert Peter, Ma, Jun, Huang, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571863/
https://www.ncbi.nlm.nih.gov/pubmed/33078214
http://dx.doi.org/10.1007/s00432-020-03426-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571863/
https://www.ncbi.nlm.nih.gov/pubmed/33078214
http://dx.doi.org/10.1007/s00432-020-03426-0

Ejemplares similares